China investment will continue throughout 2011 and beyond as big pharma seeks to establish a strong presence in the rapidly growing and lucrative market ... [Full Story]
NewBridge Pharmaceuticals to Commercialize Ebernet in the AfMET Region
April 10, 2012
NewBridge Pharmaceuticals today announced that it has entered into an exclusive license and supply agreement to commercialize Ebernet in the AfMET region ...
ShangPharma Subsidiary and Jiangsu Hengrui Form Partnership
September 15, 2011
Through the partnership, ChemPartner and Hengrui will initially collaborate on the development of novel therapeutic mAbs in a major therapeutic area ...
WuXi on the Right Track With 24% Growth in Revenues
March 10, 2011
During 2010, WuXi's sales totaled $334.1 million. The company predicts it'll reach around $400 million in 2011, a steady progression from an enterprise ...
Covance Receives AAALAC Accreditation in Shanghai, China
March 08, 2011
Covance continues to invest in China to offer its clients a growing range of preclinical safety assessment services to help pharmaceutical and biotechnology companies ...
WuXi PharmaTech Acquires Abgent
October 13, 2011
Abgent brings to WuXi new product lines of biological research reagents for drug discovery and basic research to expand its service offering to its existing customers ...
WuXi to Add Clinical Services in China
August 16, 2011
WuXi is entering the Chinese clinical trial services sector to help international clients introduce products in the high-growth country, according to Outsourcing-Pharma ...
Sundia MediTech Appoints Senior VP for its Chemistry Services
July 03, 2009
Sundia MediTech announced today that Dr. Chen Chen has been appointed Senior Vice President of Chemistry Services ...
Executive Moves: WuXi AppTec
June 22, 2009
Felix Hsu has been appointed senior vice president of WuXi AppTec U.S. In his new role, Mr. Hsu will be responsible for WuXi's U.S. business ...
other headline news
- Syntagon Launches Shanghai Sourcing Operations
- Shanghai ChemPartner Receives Award of Excellence...
- Jubilant Organosys Sees Revenues to Jump in FY 2010
- Charles River Labs Looking for Second China Facility
- PPD to Acquire BioDuro, a China-based Preclinical...
- SIRO ClinPharm and Advanced Clinical Trial...
- SIRO Clinpharm Selects Oracle's Life Sciences...
- Shanghai ChemPartner Opens European Headquarters
- Kemwell and Boehringer Collaborate on Biologics
- PPD To Expand Central Lab into Singapore
Useful Links
ChinaBioToday focuses exclusively on the rapidly evolving biotech and life science industry in China.
PharmaChinaOnline is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector.
Pharma Asia features articles on research and technology relevant to the industry and offers news and market trends.
Pharma Asia News features articles on research and technology relevant to the industry and offers news and market trends.
Pharmabiz is a comprehensive portal on the Indian pharmaceuticals industry, promoted by Saffron Media Pvt. Ltd. in Mumbai.
A Fresh View into Global Clinical Trials in China
January 05, 2011
International Multi-center Clinical Trials are considered a quick method for pharmaceutical companies to ...
Trial Initiation in South Korea Rose Dramatically
September 08, 2010
Clinical trials initiated annually in South Korea increased by 150 per cent between 2006 and 2009 ...
China Medical Device Trials - Current and Beyond
March 08, 2010
In China, regulating medical device clinical trials is still in the beginning stages and changes are being made ...
Newsletter
Subscribe to our FREE e-Newsletter and be alterted with the latest developments in industry
China has Strategic Advantage in R&D Outsourcing
October 20, 2010
China has the advantages of scientific expertise and comprehensive infrastructure, which are critical for drug discovery activities ...
Asia Pacific Trial Sector Poised for Continued Growth
August 26, 2010
The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients ...
CMOs in India, China to Grow at 20 Percent
February 12, 2010
The economic pressures of the past 18 months have clearly accelerated the cost reduction efforts ...
quick vote
Cabazitaxel and Prednisone Reduce Risk of Death for mHRPC Patients
October 27, 2010
The data demonstrated that Jevtana in combination with prednisone reduced the risk of death by 30 percent ...
Poor Glucose Control is Associated with Cardiovascular Risk
October 12, 2010
Of particular interest is the increase in cardiovascular risk for those with IFG/IGT as well as those with diabetes ...
Protein Identified to Curb Severe Inflammation
May 14, 2009
Recent work highlighted the importance of WIP1 as an effective suppressor of inflammation ...
Key References
Pharma 2020: Virtual R&D - Which path will you take?
Exploring how pharma companies could dramatically improve the R&D productivity ...
Global pharma looks to India: Prospects for growth
India now has a growing and increasingly sophisticated pharmaceutical industry of its own ...
Contract Research Organizations in Asia 2010
This report on Asian CROs provides a comprehensive list of clinical research organizations throughout Asia ...

TOP STORY